| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |